# Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates

> **NCT03022253** · PHASE3 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 44 (estimated)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **BIOLOGICAL:** Liberal platelet transfusion
- **BIOLOGICAL:** Restrictive platelet transfusion
- **DRUG:** Paracetamol
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT03022253
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-03-20
- **Final completion:** 2017-03-20
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022253, "Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03022253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*